Cell Adherent Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Get latest articles and stories on Business at LatestLY. Geneva [Switzerland], October 2: Swiss-based medical technology company MedAlliance has been acquired by Cordis for a 2022 investment of USD 35M and a 2023 upfront closing payment of USD 200M, together with regulatory achievement milestones of up to USD 125M and commercial milestones of up to USD 775M through 2029, for a total consideration of up to USD 1.135 Billion.  Business News | MedAlliance Acquired by Cordis for Up to USD 1.135 Billion.

GENEVA, Switzerland, Oct. 2, 2023 /PRNewswire/ -- Swiss-based medical technology company MedAlliance has been acquired by Cordis for a 2022 investment of

MedAlliance has announced enrollment of over 1,660 patients in its ground breaking SELUTION DeNovo coronary randomized

MedAlliance has announced completion of patient enrollment in the SAVE Clinical Trial with the SELUTION SLR(TM) 018 DEB (drug-eluting balloon) for the treatment of failed AVF (arteriovenous fistulas) in renal dialysis patients. SELUTION SLR is a

/PRNewswire/ -- MedAlliance has announced completion of patient enrollment in the SAVE Clinical Trial with the SELUTION SLR™ 018 DEB (drug-eluting balloon) for...